$Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer$

Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer

Wolpin, B. M.; Hezel, A. F.; Abrams, T.; Blaszkowsky, L. S.; Meyerhardt, J. A.; Chan, J. A.; Enzinger, P. C.; Allen, B.; Clark, J. W.; Ryan, D. P.; Fuchs, C. S.

期刊名称Journal of Clinical Oncology
作者Wolpin, B. M.; Hezel, A. F.; Abrams, T.; Blaszkowsky, L. S.; Meyerhardt, J. A.; Chan, J. A.; Enzinger, P. C.; Allen, B.; Clark, J. W.; Ryan, D. P.; Fuchs, C. S.
卷第27卷
期第2期
印刷ISSN0732-183X
电子ISSN1527-7755
文件大小143.50KB
发表时间2009-01-10
DOI10.1200/JCO.2008.18.9514
页码193-198

发现好书期刊，享受阅读乐趣

Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer